Literature DB >> 20971116

Survivin signalling in the heart.

Bodo Levkau.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20971116     DOI： 10.1016/j.yjmcc.2010.10.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  4 in total

1.  Survivin-specific T cell receptor targets tumor but not T cells.

Authors:  Caroline Arber; Xiang Feng; Harshal Abhyankar; Errika Romero; Meng-Fen Wu; Helen E Heslop; Patrick Barth; Gianpietro Dotti; Barbara Savoldo
Journal:  J Clin Invest       Date:  2014-11-21       Impact factor: 14.808

2.  Protective effect of survivin in Doxorubicin-induced cell death in h9c2 cardiac myocytes.

Authors:  Beom Seob Lee; Soo Hyuk Kim; Taewon Jin; Eun Young Choi; Jaewon Oh; Sungha Park; Sang Hak Lee; Ji Hyung Chung; Seok-Min Kang
Journal:  Korean Circ J       Date:  2013-06-30       Impact factor: 3.243

3.  C-reactive protein inhibits survivin expression via Akt/mTOR pathway downregulation by PTEN expression in cardiac myocytes.

Authors:  Beom Seob Lee; Soo Hyuk Kim; Jaewon Oh; Taewon Jin; Eun Young Choi; Sungha Park; Sang-Hak Lee; Ji Hyung Chung; Seok-Min Kang
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

4.  Simvastatin Protects Cardiomyocytes Against Endotoxin-induced Apoptosis and Up-regulates Survivin/NF-κB/p65 Expression.

Authors:  Lana Nežić; Ranko Škrbić; Ljiljana Amidžić; Radoslav Gajanin; Kamil Kuča; Vesna Jaćević
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.